EPID Research

Espoo, Finland Founded: 2010 • Age: 16 yrs Acquired By StatFinn
Pharmacoepidemiological research services are offered to life sciences firms.

About EPID Research

EPID Research is a Healthcare company based in Espoo (Finland) founded in 2010, and was acquired by StatFinn in January 2017. Pharmacoepidemiological research services are offered to life sciences firms. Its focus areas include Biopharma Outsourcing.

Company details

EPID Research was founded in 2010 in Espoo, Finland, and merged with StatFinn in January 2017. As a contract research organization, real-world evidence and pharmacoepidemiological studies are provided to pharmaceutical companies, health care organizations, and authorities. Data from health registers, electronic medical records, and biobanks are utilized to assess drug safety, effectiveness, adverse effects, and costs. Expertise is maintained in oncology, diabetes, and cardiovascular diseases.

  • Headquarters Espoo, Finland
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website epidresearch.com
  • Social LinkedIn X
  • Acquired by StatFinn (Jan 2017)
Key Metrics

Investors in EPID Research

EPID Research has secured backing from 1 investor. Prominent investors backing the company include StatFinn.

All
InvestorDescriptionFounded YearDomainLocation
CRO offering data management, biostatistics, and statistical programming services
2005statfinn.fiEspoo, Finland
Premium access

Investor details for EPID Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of EPID Research

2 dated milestones of EPID Research across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded EPID Research is founded.
  2. Exit Acquired by StatFinn.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about EPID Research

EPID Research was founded in 2010.

EPID Research is headquartered in Espoo, Finland.

EPID Research was founded in 2010 in Espoo, Finland, and merged with StatFinn in January 2017. As a contract research organization, real-world evidence and pharmacoepidemiological studies are provided to pharmaceutical companies, health care organizations, and authorities. Data from health registers, electronic medical records, and biobanks are utilized to assess drug safety, effectiveness, adverse effects, and costs. Expertise is maintained in oncology, diabetes, and cardiovascular diseases.

EPID Research has 1 investor. Key investors include StatFinn.

Yes. EPID Research was acquired by StatFinn in January 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available